HDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?

Expert Rev Cardiovasc Ther. 2017 May;15(5):343-344. doi: 10.1080/14779072.2017.1313115. Epub 2017 Apr 10.

Authors

Emiel P C van der Vorst^{1

2}, Kosta Theodorou¹, Erik A L Biessen^{1

3}, Marjo M P C Donners¹

Affiliations

¹ a Department of Pathology, Cardiovascular Research Institute Maastricht , Maastricht University , Maastricht , The Netherlands.
² b Institute for Cardiovascular Prevention , Ludwig-Maximilians-University , Munich , Aachen , Germany.
³ c IMCARIM , Uniklinikum Aachen , Germany.

PMID: 28349717
DOI: 10.1080/14779072.2017.1313115

No abstract available

Keywords: High density lipoproteins; atherosclerosis; inflammation; macrophages.